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Abstract
Background: Members of the TGF-b superfamily are characterized by a highly promiscuous ligand-receptor interaction as is
readily apparent from the numeral discrepancy of only seven type I and five type II receptors available for more than 40
ligands. Structural and functional studies have been used to address the question of how specific signals can be deduced
from a limited number of receptor combinations and to unravel the molecular mechanisms underlying the protein-protein
recognition that allow such limited specificity.
Principal Findings: In this study we have investigated how an antigen binding antibody fragment (Fab) raised against the
extracellular domain of the BMP receptor type IA (BMPR-IA) recognizes the receptor’s BMP-2 binding epitope and thereby
neutralizes BMP-2 receptor activation. The crystal structure of the complex of the BMPR-IA ectodomain bound to the Fab
AbD1556 revealed that the contact surface of BMPR-IA overlaps extensively with the contact surface for BMP-2 interaction.
Although the structural epitopes of BMPR-IA to both binding partners coincides, the structures of BMPR-IA in the two
complexes differ significantly. In contrast to the structural differences, alanine-scanning mutagenesis of BMPR-IA showed
that the functional determinants for binding to the antibody and BMP-2 are almost identical.
Conclusions: Comparing the structures of BMPR-IA bound to BMP-2 or bound to the Fab AbD1556 with the structure of
unbound BMPR-IA shows that binding of BMPR-IA to its interaction partners follows a selection fit mechanism, possibly
indicating that the ligand promiscuity of BMPR-IA is inherently encoded by structural adaptability. The functional and
structural analysis of the BMPR-IA binding antibody AbD1556 mimicking the BMP-2 binding epitope may thus pave the way
for the design of low-molecular weight synthetic receptor binders/inhibitors.
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Introduction
Bone morphogenetic proteins (BMPs) are secreted multifunc-
tional signaling proteins that belong to the TGF-b (Transforming
Growth Factor b) superfamily [1]. Members of the BMP subfamily
play important roles during development, maintenance and
regeneration of tissues and organs in almost all vertebrates and
non-vertebrate animals [2,3]. Their malfunction during the
signalling process can lead to multiple diseases including skeletal
malformations, cardiovascular and metabolic diseases, muscular
disorders and cancer [4].
Signal transduction of TGF-b proteins is initiated by binding
to two types of receptors named type I and type II [1,5]. Both
receptor classes share a cysteine-rich extracellular domain, a
single transmembrane segment and a cytoplasmic serine/
threonine-kinase domain. Upon receptor oligomerization, the
type I receptor is phosphorylated at its intracellular glycine-
serine-rich domain (the so-called GS box) by the constitutively
active type II receptor kinase thereby activating the SMAD
signalling cascade affecting transcription of responsive genes in
the nucleus [6].
One hallmark of the TGF-b ligand-receptor interaction is its
high promiscuity [7], with only seven type I receptors and five type
II receptors being known for more than 40 ligands [1,8]. Thus one
receptor subtype usually interacts with several different ligands.
Furthermore, various ligands have been shown to interact with
different receptor chains of both type I and type II. For instance,
BMP-2 recruits both type I receptors, BMPR-IA and BMPR-IB,
into a binary complex with high affinity. A low affinity type II
receptor (either BMPR-II, ActR-II or ActR-IIB) is then bound by
the binary complex, thereby forming a heterotetrameric receptor
complex [7].
In recent year, several crystal structures of BMPs bound to the
extracellular domains of type I and type II receptors have been
determined in recent years to unravel the molecular mechanisms
underlying promiscuity and specificity [9,10,11,12,13,14]. Three
crystal structures of the extracellular (EC) domain of BMPR-IA in
complex with BMP-2 are described, showing that binding and
structure of BMPR-IA are highly conserved, although crystallisa-
tion conditions varied in all three cases [9,11,14]. Recently, the
NMR structure of unbound, free BMPR-IAEC was determined,
showing that its core structure is largely superimposable upon the
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binding epitope of BMPR-IA to BMP-2 differs markedly due to
the absence of a short a-helix in the b4b5-loop of the free receptor.
Importantly, the a-helical segment of BMPR-IA is in the centre of
the BMP-2 binding epitope and carries the hot spot of binding,
Phe85 and Gln86, for binding to BMP-2. Upon complex
formation with BMP-2, a disorder-to-order transition occurs in
the receptor, indicating an inherent flexibility of a main binding
element. Similarly, BMPR-IB also seems to exhibit inherent
flexibility in the ligand binding epitope, which in the case of
binding to GDF-5 is used to generate ligand binding specificity
[13].
Here we report the crystal structure of BMPR-IAEC bound to
the BMP-2 activity-neutralizing Fab AbD1556. Structural analysis
showed that the b4b5-loop of BMPR-IA does not adopt an a-
helical conformation as seen in the complex BMP-2:BMPR-IAEC,
but rather exhibits an extended conformation similar but not
identical to the NMR structure of BMPR-IA. Therefore, the
formation of the a-helix in BMPR-IA’s b4b5-loop seems to
depend on the nature of the binding partner and is thus not
‘‘imprinted’’ during complex formation with a protein binding
partner. Surprisingly, despite the differences in the structural
epitopes of BMPR-IA for Fab- and BMP-2 binding, the same
residues in BMPR-IA seem to be involved in recognition and
binding to BMP-2 and AbD1556. Taken together, these results
provide new and interesting insights for our understanding of
protein-protein interactions and protein recognition.
Materials and Methods
Preparation of BMPR-IAEC and selection of Fab fragments
The extracellular domain of human BMPR-IA (BMPR-IAEC)
(amino acids 1–129 of the mature part, SWISSPROT entry
P36894) and its variants were expressed as thioredoxin-fusion
proteins as described [16]. Mutations were introduced by two-step
PCR-based targeted mutagenesis. Wildtype and variant proteins of
BMPR-IA were purified using an identical protocol, thus
differences in the purification could possibly indicate BMPR-IA
variants with non-native fold. Protein homogeneity was analyzed
by reversed-phase HPLC chromatography, SDS-PAGE and mass
spectrometry.
Recombinant Fab proteins were obtained from AbD-Serotech
(Martinsried). Initially, eight antibodies against the extracellular
domain of BMPR-IA were selected from panning of a HuCal
phage library with biotinylated BMPR-IAEC immobilized on a
resin [17,18,19]. Antibodies were characterized by western blot,
cell assays and interaction analysis. Two of these Fabs, AbD1556
and AbD1564, showed high nanomolar affinities for BMPR-IA
and could neutralize BMP-2 activity in cell-based assays. Both Fab
proteins used in this study contained a non-cleavable Strep-Tag at
the C-terminus of the heavy chain (peptide sequence SAWSHPQ-
FEK), which was not removed for crystallization.
Crystallization of Fab-receptor complexes
A binary complex of AbD1556 bound to BMPR-IAEC was
formed by mixing AbD1556 with a 1.1-fold molar excess of
BMPR-IAEC. The protein complex was purified by gel filtration
using a Superdex200 HR10–30 column (GE Healthcare) and
10 mM HEPES pH 7.4, 150 mM NaCl. Fractions containing the
antibody-receptor complex in equimolar stoichiometry were
combined, and the protein solution was concentrated up to
16.4 mg ml
21 in 10 mM HEPES pH 7.4, 150 mM NaCl using
ultrafiltration. Initial screening for crystallization conditions was
performed using a sparse matrix setup obtained from successful
crystallization conditions reported for antibody-protein complexes
in the RCSB databank and several commercial screens (Hampton,
MDL) [20]. Single crystals of the AbD1556:BMPR-IA complex
could be grown by mixing 2 ml protein solution and 1 ml reservoir
solution in hanging drop setups at room temperature over a
reservoir solution of 100 mM Tris-HCl pH 7.0, 20% (w/v) PEG
8000 and 10% (w/v) glucose as cryoprotectant. Protein crystals
grew to a final size of approximately 1506150640 mm within 7
days. Crystal suitable for data acquisition diffracted to a resolution
limit of up to 2.7 A ˚ and had the monoclinic space group P21 with
unit cell parameters of a=89.32 A ˚, b=129.25 A ˚, c=100.24 A ˚
and a=c=90u and b=92.27u.
X-ray data acquisition and structure analysis
A native dataset of the Fab AbD1556-BMPR-IAEC complex
was acquired from a single crystal on a X-ray home source (X-ray
generator Rigaku MicroMax007 equipped with Osmic VariMax
HighRes optics and an image plate system RAXIS-IV++) at 100
K. Diffraction data were indexed and integrated using the software
CrystalClear 1.3.6 (Rigaku). The dataset used has 95.3%
completeness for the resolution range 30.4 to 2.7 A ˚ and an Rsym
of 0.08. Initial phasing was performed by molecular replacement
using the structure of the human Fab PDB entry 1AQK as
template and using the software Phaser [21]. Calculating the
Matthew’s coefficient indicated three or four Fab:receptor
complexes per asymmetric unit (3 AbD1556:BMPR-IA: Vm
3.06 A ˚ 3/Da or 60% solvent content; 4 AbD1556:BMPR-IA: Vm
2.29 A ˚ 3/Da or 46% solvent content). To solve this ambiguity, a
native Patterson map analysis and a selfrotation calculation were
performed using the software Phenix xtriage and GLRF providing
evidence for the presence of four AbD1556:BMPR-IA complexes
per asymmetric unit. The structure was then solved by molecular
replacement using the software Phaser and the structures of
BMPR-IAEC (from the complex BMP-2:BMPR-IA, PDB entry
1REW) and of the Fab with high affinity for the tetanus toxoid
(PDB entry 1AQK). Using a stepwise search procedure in the
software Phaser all four AbD1556:BMPR-IA complexes could be
identified in the asymmetric unit of the crystal. The structure was
then refined in an iterative procedure via refinement using the
software Refmac 5.02 [22] and manually rebuilding using
Quanta2006 (Accelrys). For refinement non-crystallographic
symmetric (NCS) was employed for the four AbD1556:BMPR-
IAEC complexes in the asymmetric unit with the light and heavy
chains of the Fab and BMPR-IA forming three individual NCS
groups. All three NCS groups were then restrained with tight
positional restraints throughout the refinement in Refmac 5.02,
but the heavy chain of AbD1556 molecule 1 (chain H) was
excluded from NCS refinement as the strands b6 and b7 of the
constant heavy (CH) domains were shifted by about 1.4 to 1.8 A ˚
compared to the other three CH domains due to differences in the
crystal lattice contacts (see Fig. 1c).
To account for anisotropy in the diffraction data 20 TLS groups
were employed in the refinement, using 1 TLS group for each
constant and variable region of the light and heavy chain of the
Fab as well as for BMPR-IA. In the final round of model building
aF obs-Fcalc difference electron density map was used to identify
solvent molecules. The final model exhibits an R-factor of 0.234
(Rfree 0.280) and consists of 15323 protein atoms and 27 water
molecules. In all four complexes in the asymmetric unit residues
Pro34 to Val118 of BMPR-IA as well as residues Ile2 to Thr211 of
the light chain of AbD1556 could be modelled, for the 33 N-
terminal and the 11 C-terminal residues of BMPR-IA no traceable
electron density was observed. Similarly, Asp1 and residues
Glu212 to Ala213 of the AbD1556 light chain could not be
A Fab:BMPR-IA Complex
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four AbD1556 moieties electron density allowed tracing of
residues Gln1 to Lys221 only for one heavy chain (chain J),
whereas several residues in the loops of the constant regions of the
other three AbD1556 heavy chain could not be modelled (chain
H: Lys136 to Thr142, Ser194 to Gln199, Lys221; chain I: Lys136
to Gly140, Lys221; chain J: Lys136 to Gly141). Residues Ser222 to
Phe224 and the peptide sequence of the additional Strep-Tag at
the C-terminus of the AbD1556 constant region heavy chain could
not be traced in the electron density in any of the four AbD1556
moieties. Regions immediately ahead of or behind stretches of
missing residues usually exhibit high temperature factors (B-factors
$120) indicating dynamic disorder (Fig. S1). Conformingly, the
affected loop areas have little or no crystal lattice contacts that
could stabilize a defined loop conformation (Fig. S2). Further
statistics for data acquisition and structure refinement are
compiled in Table 1.
Surface plasmon resonance
Interaction analysis was performed on a Biacore 2000 system
(GE Healthcare, Biacore). All measurements were performed at
room temperature. BMP-2 and the antibody proteins were
biotinylated using LC-NHS-biotin (Pierce) in 2fold molar excess.
Biotinylated proteins were immobilized on flow cells 2, 3 and 4 of
a streptavidin-coated CM5 sensorchip (GE Healthcare). Binding
of wildtype and mutant BMPR-IAEC was measured using HBS500
buffer (10 mM HEPES, 500 mM NaCl pH 7.4, 3.4 mM EDTA,
0.005% surfactant P20) at a flow rate of 10 ml min
21. Between
measurements the biosensor surfaces were regenerated by
perfusing with 4 M magnesiumchloride for 2 min. Sensorgrams
were recorded at analyte concentrations of 1000, 500, 250, 125,
and 62.5 nM. All measurements were corrected for non-specific
interactions and bulk face effects by subtracting a control
sensorgram recorded for flow cell 1 (blank immobilization). Data
were evaluated employing a simple 1:1 Langmuir-type interaction
model and using the software BIAevaluation version 2.0. Apparent
binding constants (KD) were obtained from the dose dependency
of equilibrium binding and/or from the kinetic rate constants for
complex formation (kon) and dissociation (koff) respectively. The
mean standard deviations for all KD values were ,50%.
Biological activity of Fab proteins in cell line C2C12
The mouse myoblast cell line C2C12 (ATCC, No. CRL-1772)
was cultured in DMEM medium containing 10% fetal calf serum
(FCS), and antibiotics (100 U ml
21 penicillin G and 100 mgm l
21
streptomycin). For alkaline phosphatase (ALP) expression assays,
the cells were incubated for 72 h in medium containing 2% FCS
and supplemented with BMP-2 in 96-well microplates [23]. After
cell lysis, ALP activity was measured by p-nitrophenylphosphate
conversion using an ELISA reader at 405 nm. To assess the effect
of the antibodies on cell signaling, Fab proteins and BMP-2 were
added simultaneously. For such inhibition assays the BMP was
added at the concentration required for half-maximal response
(EC50), which was determined in a standard ALP-assay before. All
experiments were performed in duplicate and the data presented
were obtained from at least two independent experiments (Fig.
S3).
Results
Crystallization of the BMP receptor-Fab complex
BMPR-IAEC/AbD1556
To determine the structural plasticity of the BMP receptor IA
binding epitope for binding to BMP-2 we prepared Fab proteins
raised against the extracellular domain of BMPR-IA (obtained in
collaboration with AbD-Serotech). The antibody fragments were
generated by phage display using biotinylated BMPR-IA in a so-
called solution panning [19] and employing the HuCal Fab library
of AbD-Serotech [17,18]. The binding properties of eight different
Fabs directed against BMPR-IAEC were analyzed using surface
plasmon resonance and with respect to their BMP-2 neutralizing
activity, using an alkaline phosphatase (ALP) expression assay. For
two Fab proteins, AbD1556 and AbD1564, a BMP-2 neutralizing
effect was observed, suggesting that these two antibody proteins
bind BMPR-IA via the same or an overlapping epitope with BMP-
2. Complexes of both Fab proteins with BMPR-IAEC were
prepared and subjected to crystallization trials. Although crystals
of both complexes could be obtained, crystals of the complex
AbD1564:BMPR-IAEC diffracted only to low resolution and single
crystals could not be obtained. In contrast, large crystals of the
complex AbD1556:BMPR-IAEC could be reproducibly grown,
which also diffracted to high resolution. SDS-PAGE analysis of
protein crystals confirmed that these crystals contain both proteins,
the Fab AbD1556 and the BMPR-IA ectodomain.
A complete diffraction dataset of this Fab-BMP receptor
complex was measured. The structure was determined by
molecular replacement and using the structure of a Fab (PDB
entry 1AQK, [24]), having high primary structure similarity as a
search template. Since analysis of the unit cell content suggested
the presence of up to four Fab:receptor complexes in the
asymmetric unit, it was unclear whether all Fab fragments would
have a BMPR-IA moiety bound. Using the software Phaser for the
molecular replacement and an iterative search procedure, four
Fab AbD1556:BMPR-IAEC complexes were found in the
asymmetric unit. The initial search using the full Fab fragment
of a Fab directed against Tetanus toxoid, which shared the highest
amino acid similarity with the Fab antibodies of AbD Serotec,
failed, suggesting that the architecture of the Fab of AbD1556 in
complex with BMPR-IAEC differs from the template. A compar-
ison of the final structure of AbD1556 (Fig. 1A,B) and 1AQK
indeed shows that although the orientations of both constant
regions of heavy (CH) and light (CL) chain as well as of both
variable regions of constant and heavy chain are identical, the
orientation of the variable region towards the constant region
differs significantly in both Fab proteins, AbD1556 and the
template Fab PDB entry 1AQK. Superposition of the variable
Figure 1. Architecture of the Fab:receptor complex of AbD1556:BMPR-IAEC. (A) Ribbon representation of the Fab:receptor complex of
BMPR-IA bound to AbD1556. The receptor ectodomain (Pro34 - Val118) is shown in green, the heavy chain of AbD1556 is shown in cyan, the light
chain of the Fab is marked in magenta. Complementary determining regions (CDRs), constant and variable regions are indicated. (B) As in (A) but
rotated by 150u around the y-axis. (C) Structural alignment of the four Fab:BMPR-IA complexes of the asymmetric unit. The four structures of BMPR-
IAEC are shown in different shades of green, similarly the Fab heavy and variable regions of the four Fab molecules of the asymmetric unit are
indicated in different shades of cyan and magenta. Only the Ca-trace is shown. Structural superposition was performed using all Ca-atoms of the four
Fab molecules thereby showing slight, but significant differences in the location of the four BMPR-IA molecules (,1A ˚). (D) As in (C) but structural
alignment was performed on the Ca-atoms of BMPR-IA. (E) As in (C) but side chains of the four BMPR-IA molecules of the asymmetric unit are shown,
illustrating the positional shifts of the BMPR-IA molecules in the Fab binding site. (F) As in (E) but with structural alignment performed on the Ca-
atoms of the four BMPR-IA molecules.
doi:10.1371/journal.pone.0013049.g001
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constant regions reorient by 38u and 43u.
Architecture of the Fab AbD1556:BMPR-IA complex and
epitopes involved in binding
A comparison of the four complexes in the asymmetric unit
suggests that all four of the Fab:BMPR-IAEC complexes are almost
identical, as a global fitting yields r.m.s. deviations of 0.6 to 0.7 A ˚
for all Ca-atom positions. However, a detailed analysis reveals that
the substructures, i.e. the Fab fragment or the receptor
ectodomain, are identical within the accuracy of the acquired
data. Backbone as well as side chain atoms of the four Fab
fragments in the asymmetric unit superimpose almost perfectly
with most pairings exhibiting an root-mean-square deviation
(r.m.s.d.) of 0.6 A ˚ or less, and superposition of the four BMPR-IA
receptor ectodomains yields an r.m.s.d. of 0.16 A ˚ or less.
However, when the Fab molecules are structurally aligned a
comparison of the bound BMPR-IA ectodomains shows that the
receptor molecules shift slightly in the four complexes in the
asymmetric unit (Fig. 1C–F). In the Fab:BMPR-IAEC complex 1
of the asymmetric unit the BMPR-IA moiety is shifted by 0.8 to
1A ˚ towards the heavy chain compared to the three other
Fab:receptor ectodomain complexes of the asymmetric unit. Both
the Fab moiety as well as the receptor ectodomain moiety seem to
act as rigid bodies, thus these differences show that a small
reorientation of BMPR-IA within the binding epitope of the
antibody protein is possible.
Upon complex formation about 1110 A ˚ 2 solvent-accessible
surface area of the Fab fragment and 1230 A ˚ 2 of the BMP
receptor ectodomain are buried. As expected from other antigen-
antibody structures the complementary determining region (CDR)
3 of the heavy chain contributes, by far, the most to the buried
surface area (570 A ˚ 2), as the CDR3 of the variable heavy chain
domain (VH) is in the centre of the antibody-antigen interface
(Fig. S4). In the light chain it is CDR1 and 2 that contribute
significantly (165 and 95 A ˚ 2) to the antibody interface, whereas
CDR3 does not seem to be much involved in the binding (buried
surface area 59 A ˚ 2) due to the location of VL CDR3 at the
periphery of the BMPR-IA binding site. In total, the CDRs of the
light chain contribute only 319 A ˚ 2 surface area to the interface, in
contrast to the CDRs of the heavy chain, which all together deliver
almost 800 A ˚ 2 of interface area. One possible explanation for the
uneven contribution of the VH and VL segments to the interface is
the location of BMPR-IAEC on top of the antigen-binding site of
the Fab AbD1556. The VL domain is placed opposite of the b1b2-
loop and the C-terminal end of b-strand 4 of BMPR-IA, whereas
the VH domain covers most of the three-stranded central b-sheet
and a large part of the b4b5-loop of the receptor ectodomain
(Fig. 2A).
In the case of BMPR-IA, the interfacial residues of the
AbD1556:BMPR-IAEC complex are almost evenly distributed
over the slightly concave site of the three-stranded b-sheet, which
consists of the b-strands b3, b4 and b5, but the Fab-binding
epitope also involves several residues from the b1b2-loops as well
as the b4b5-loops. A comparison with BMPR-IAEC bound to
BMP-2 (PDB entry 1REW) shows that the binding epitopes on
BMPR-IA overlap heavily in both complexes (Fig. 2B–D); even
the amount of interface area involved for BMPR-IA is quite
similar (BMPR-IAAbD1556 1230 A ˚ 2 vs. 1200 A ˚ 2 for BMPR-IABMP-
2). A closer inspection, however, also shows differences regarding
to the extent that individual residues participate in the interface
(Fig. S4). In the BMP-2:BMPR-IAEC complex the b1b2-loop of
the receptor ectodomain is more tightly packed into the interface
as compared to the AbD1556:BMPR-IAEC complex, whereas in
Table 1. Data acquisition and structure refinement.
Crystals and data processing AbD1556:BMPR-IAEC complex
Beamline home source
Wave length 1.5418 A ˚
Space group P21
Unit cell a=89.32, b=129.25 A ˚, c=100.24 A ˚
a=c=90u, b=92.27u
Resolution 30.4 - 2.70 A ˚
(2.80 - 2.70 A ˚)
a)
Number of reflections collected 155123 (15796)
Number of unique reflections 59539 (6237)
Completeness 95.3 (97.8) %
Multiplicity 2.6 (2.6)
Rsym for all reflections 8.0 (34.1) %
,Intensity/s. 8.2 (2.7)
x
2 0.98 (1.19)
Refinement statistics
Rcryst 23.4 (32.0) %
Rfree (test set 5%) 28.0 (33.8) %
NCS groups
b) 3 (heavy chain, light chain, receptor)
heavy chain, residues 1–221
light chain, residues 2–220
BMPR-IA, residues 34–117
TLS groups 20 (1 for each CH,C L,V H,V L and BMPR-IA)
r.m.s. deviation
Bonds 0.013 A ˚
Angles 1.624u
Torsion period 1 7.650u
Torsion period 2 38.169u
Torsion period 3 21.787u
Torsion period 4 22.560u
NCSheavy chain 0.07 A ˚
NCSlight chain 0.10 A ˚
NCSBMPR-IA 0.07 A ˚
Average B-Factor
c) 64.1 A ˚2 (min. 36.9 A ˚2; max. 158.1 A ˚2)
Coordinate error (based on Rfree) 0.41 A ˚
Procheck analysis
d)
most favored region 85.7% (1466)
additional allowed region 13.9% (237)
generously allowed region 0.5% (8)
disallowed region 0.0% (0)
a) Statistical analysis for the highest resolution shell is shown in parentheses.
b) Non-crystallographic symmetry restraints were applied between the four
complexes in the asymmetric unit. One NCS group was defined for the heavy
chain, the light chain and the receptor ectodomain of BMPR-IA and restrained
to the respective molecules in the other three AbD1556:BMPR-IA complexes
except for the heavy chain of AbD1556 molecule 1. As strict NCS was not
applicable (see also Fig. 1C–F) tight positional NCS restraints were used
throughout the refinement using Refmac 5.02.
c) The minimal and maximal B-factor for the backbone atoms are indicated, for a
comparison of the B-factor distribution between all four AbD1556:BMPR-IA
complexes see Fig. S1.
d) The numbers in parentheses indicate the absolute number of residues
present in the respective area of the Ramachandran plot.
doi:10.1371/journal.pone.0013049.t001
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BMPR-IA are most deeply buried.
Seventeen hydrogen bonds between the Fab and the receptor
ectodomain document the rather polar character of the antibody-
receptor interaction (Table 2, Fig. 3A). Most hydrogen bonds to
t h eF a bi n v o l v et h eb4b5-loop segment of BMPR-IA (eight
hydrogen bonds for residues Glu81 to Arg96), which also carries
the main determinants for binding to BMP-2 [11]. This suggests
that either amino acid composition or the conformation of this
loop render this segment ‘‘sticky’’ for protein-protein interactions.
Two residues in the Fab-receptor complex form hydrogen bond
clusters or networks. Four hydrogen bonds emanate from the
guanidinium group of Arg104 of the Fab heavy chain to the
carboxylate group of BMPR-IA Glu81, forming a bi-dentate
saltbridge, and two further hydrogen bonds are formed with the
backbone carbonyl of BMPR-IA Gln86 (Fig. 3B). The large
number of hydrogen bonds, together with the fact that these
residues are rather deeply buried inside the interface, indicates
that Arg104 of the Fab AbD1556 (and possibly Glu81 of BMPR-
IA as well) might represent so-called hot spots of binding. The
second independent hydrogen bond network is centred on
BMPR-IA Glu64, whose side chain carboxylate group forms
hydrogen bonds with the side chains of Arg100 and His102 of the
heavy chain of Fab AbD1556 (Fig. 3C). Both latter side chains
are pre-oriented in the interface either by an additional hydrogen
bond, i.e. Fab Arg100 to Gln94 of BMPR-IA or by hydrophobic
contacts, i.e. Fab His102 in contact to BMPR-IA Ile62 and Fab
VL Tyr48.
The structures of BMPR-IA in complex with the Fab
AbD1556 and BMP-2 differ
Due to the overlapping epitopes of Fab AbD1556 and BMP-2
on BMPR-IA one can think of the Fab AbD1556 binding epitope
as similar to an anti-idiotypic molecule mimicking BMP-2. It is
thus an interesting question whether the conformations of BMPR-
IAEC bound to either the Fab AbD1556 or BMP-2 are identical,
especially since our NMR-studies of isolated BMPR-IAEC have
shown that the majority of the BMP-2 binding epitope of BMPR-
IA is unfolded before binding [15]. The large conformational
change upon binding to BMP-2 is mostly apparent from the
formation of a short a-helix segment (helix a1) comprising residues
Gly82 to Lys88 in the b4b5-loop. This a-helix, which contains the
Figure 2. Binding epitopes of AbD1556 and BMPR-IA. (A) Stereo view of the binding epitope of BMPR-IA in the AbD1556:BMPR-IA complex.
The positions of the six CDR binding loops are shown highlighting the central location of CDR3 of the heavy chain of AbD1556. Besides CDR3 of the
heavy chain only the CDRs 1 and 2 of the light chain make significant contact with BMPR-IA. (B,C) Open book view of the binding epitopes of
AbD1556 (B) and BMPR-IAEC (C). The binding epitope is color-coded with hydrophobic amino acid residues (A, C, F, G, H, I, L, M, P, V, W, and Y) in dark
gray, acidic residues in red (D, E), basic residues in blue (K, R) and polar but uncharged residues in green (N, Q, S, T). Residues in the epitope of
AbD1556 originating from the light chain are indicated by brighter color and by italic labels. (D) The binding epitope of BMPR-IA for binding to BMP-2
(orientation of BMPR-IA in (C) and (D) are identical) showing that both epitopes are highly similar and overlap almost perfectly.
doi:10.1371/journal.pone.0013049.g002
A Fab:BMPR-IA Complex
PLoS ONE | www.plosone.org 6 September 2010 | Volume 5 | Issue 9 | e13049binding hot spots for the interaction of BMPR-IA with BMP-2
[11], is absent in the free form of BMPR-IA, but formed
spontaneously in NMR-titration experiments using the helix-
inducing agent trifluoroethanol [15]. It was thus suggested that the
helical element would be in a so-called status nascendi thereby
forming instantaneously upon changes in the environment without
the need of a BMP-2 ‘‘casting mold’’.
However, a comparison of BMPR-IA bound to Fab AbD1556
and BMPR-IA bound to BMP-2 (PDB entry 1REW) clearly shows
that the helix a1 is alsoabsent in the former (Fig. 4A). This segment
of BMPR-IA adopts a rather irregular conformation with short
extended stretches, i.e. Asp84 to Cys87 and Asp89 to Pro91.
Interestingly, despite the difference in the conformations of the
b4b5-loop in the NMR structure (PDB entry 2K3G) and the
complex structure when bound to AbD1556, all other secondary
structure elements,e.g. thethree-strandedb-sheet ortheN-terminal
b-strands b1 and b2 together with the b1b2-loop, overlap almost
perfectly (Fig. 4A). Since the conformational rearrangement in
BMPR-IA could principally follow either an induced fit or a
selection of conformer mechanism, we also compared the structure
of BMPR-IA bound to Fab AbD1556 also with all the individual
structures of the NMR ensemble (Fig. 4B). However, this
comparison shows that although the loop is also irregular in the
NMR structure ensemble, there is no conformer in the ensemble,
which is identical to BMPR-IA bound to AbD1556. Moreover, the
conformation of the BMPR-IA b4b5-loop in its AbD1556 bound
form seems to be a mixture of the conformations seen in the NMR
ensemble and the BMP-2 bound form. Residues Ser90 to Ala93
overlap with the conformer ensemble present in the NMR
structures, while Asp89 to Gln86 show a helical twist similar to
the helical end in BMPR-IA when bound to BMP-2. Only the N-
terminal part of the b4b5-loop, i.e. residues Gly82 to Phe85 exhibits
a conformation which is neither present in the NMR ensemble nor
the BMP-2 bound form (Fig. 4C). Thisobservation suggests that an
induced fit mechanism, where the flexible, disordered (in its free
form) b4b5-loop BMPR-IA adopts a conformation imposed by the
binding partner. In BMP-2 the helix is formed because the highly
concave site of the wrist epitope forms a 120u spanning binding site,
which is usually seen in structural arrangements of amphipathic
helix/helices (e.g. hydrophobic cores in helical bundles). In contrast,
the binding site of the Fab is rather flat, thus the interaction to
stabilize the helical element is not sufficient and the b4b5-loop
adopts a more extended, helical-free structure.
Main binding determinants of BMPR-IA for AbD1556 and
BMP-2 are identical
As mentioned above, the structural epitopes of BMPR-IA
buried upon binding to the Fab AbD1556 or to BMP-2 overlap
Figure 3. Hydrogen bond network in the AbD1556-BMPR-IA interface. (A) Overview of the hydrogen bonding between AbD1556 (shown in
cyan and magenta for the heavy and light chain, respectively) and BMPR-IAEC (green). Only residues involved in hyydrogen bonds across the interface
are shown. (B) Zoom into the hydrogen bond cluster around Glu81 of BMPR-IA. (C) Magnification of the hydrogen bond cluster around Glu64.
doi:10.1371/journal.pone.0013049.g003
Table 2. Geometry of hydrogen bonds in the AbD1556 -
BMPR-IA interface.
BMPR-IAEC AbD1556
Distance
A ˚
Angle
NOC
a)
Hydrogen
bond
b)
E64 (OE1) H102H
c) (ND1) 2.38 151 SC-SC
E64 (OE2) R100H (NH1) 3.00 105 SC-SC
D67 (OD1) Y32H (OH) 3.06 109 SC-SC
D67 (OD2) R98H (NH2) 2.39 137 SC-SC
K79 (N) Y31L (OH) 2.70 117 MC-SC
K79 (NZ) G28L (O) 3.06 104 SC-MC
K79 (NZ) K30L (O) 2.79 100 SC-MC
K79 (NZ) N65L (OD1) 3.21 156 SC-SC
E81 (OE1) R104H (NE) 2.82 123 SC-SC
E81 (OE2) R104H (NH2) 2.46 121 SC-SC
Q86 (O) R104H (NH1) 3.08 91 MC-SC
Q86 (O) R104H (NH2) 2.96 96 MC-SC
K92 (O) T33H (OG1) 2.47 114 MC-SC
K92 (NZ) N95L (O) 2.81 124 SC-MC
Q94 (OE1) R100H (NE) 2.78 99 SC-SC
L95 (N) N31H (O) 3.03 111 MC-MC
R97 (NE) H102H (O) 2.71 132 SC-MC
mean value 2.79 115
S.D. 0.26 19
The numbers in parentheses are the distances between donor and acceptor
atoms and N-O-C angles in the AbD1556:BMPR-IA interface of complex 1 in the
asymmetric unit.
a) N, O, C are the donor-acceptor atoms; from general statistics [48] this angle is
149u615u for MC–MC hydrogen bonds and 129u618u for SC-MC and SC-SC
hydrogen bonds;
b) MC (main chain) and SC (side chain) donor/acceptor atoms;
c) H and L denote heavy and light chain of the Fab AbD1556, respectively.
doi:10.1371/journal.pone.0013049.t002
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ectodomain facilitates binding to both ligands. Therefore, a
mutational analysis of BMPR-IA was performed in order to see
whether the functional epitopes, i.e. the main binding determi-
nants for the interaction with both binding partners, are similar. If
the Fab AbD1556 would function as a BMP-2 mimic, one would
expect that the same residues play similar roles in the recognition
and binding of both partners. However, the different number of
hydrogen bonds between BMPR-IA and AbD1556 compared to
the complex of BMPR-IA and BMP-2 as well as the different
residues involved on BMPR-IA suggests that the functional
epitopes of BMPR-IA for AbD1556 and BMP-2 are markedly
different. We therefore mutated 13 receptor residues in the centre
of the contact surface. In most cases a mutation to alanine was
done, but at three positions we also substituted these residues for
Asp, Arg, or Pro (Table 3). The resulting mutant proteins were
purified, and their binding affinities were studied by surface
plasmon resonance. In order to measure comparable binding
affinities without avidity effects resulting from different oligomeric
states (BMP-2 as homodimer will bind to two receptor molecules
simultaneously if used as analyte) we immobilized both the
monovalent Fabs AbD1556 and AbD1564 (another neutralizing
anti-BMPR-IA Fab) as well as BMP-2 in different flow cells of one
biosensor chip. Each BMPR-IA variant protein was then perfused
as analyte over all three ligands in parallel, which allows for direct
comparison of the binding data (Tables 3 and 4).
It was very surprising to see that the functional epitopes of
BMPR-IA for BMP-2 and AbD1556 are highly similar despite the
structural differences in the epitopes of BMPR-IA for binding
either to BMP-2 or AbD1556. The affinities of the different
receptor mutants for BMP-2 and AbD1556 investigated here were
clearly correlated (see apparent KD’s in Fig. 5A). One set of
BMPR-IA mutants exhibits affinities for AbD1556 and BMP-2
similar to the wild type BMPR-IA. Interestingly, this set comprises
almost all of the polar residues, i.e. Glu64, Asp67, Lys79, Glu81,
Lys92, and Gln94, within the Fab-binding epitope of BMPR-IA,
which form 11 out of 15 intermolecular hydrogen bonds in the
Fab-receptor interface. Thus polar interactions, despite their large
number, seemingly do not contribute significantly to the binding
energy. This unexpected finding might be explained by two
factors. Firstly, many of these hydrogen bonds originate from side
chains of BMPR-IA residues that are located at the periphery of
the interface and, thus, might be solvent-accessible. Without
shielding from the solvent, the hydrogen bonds to the protein
partner compete with hydrogen bonds with water and the
energetic benefit for the protein-protein interaction will hence be
low. Secondly, eight of the eleven addressed hydrogen bonds are of
the type ‘‘side chain to side chain’’, meaning that the entropy cost
from decreasing the conformational flexibility of both side chains
involved in the intermolecular hydrogen bond might just be barely
paid off by the bond formed. A similar observation is reported for
the BMPR-IA:BMP-2 interaction [11], where only two of the ten
intermolecular hydrogen bonds are significant for the ligand-
receptor complex formation. Another set of BMPR-IA mutants
(Ile62, Gln86, Arg97, and Ile99) showed affinities for Fab
AbD1556 (or for BMP-2) that are 10- to 30-fold (for the
interaction with BMP-2: 20- to 40-fold) lower compared to wild
Table 3. Mutational analysis of the BMPR-IA binding
interface
a).
BMP-2 AbD1556 AbD1564
rel. app. KD
BMPR-IA WT 1.060.1 1.060.1 1.060.2
(29.762.8) (18.661.2) (55.766.6)
[P34R] 1.7 1.2 0.9
[Y39D]
b) 16.4 23.5 n.b.
[F60A]
b) n.b.
c) n.b. n.b.
[I62A] 42.4 29.1 1.8
[E64A] 1.3 2.3 0.5
[D67A] 1.0 1.7 n.b.
[M78A]
b) n.b. n.b. 3.8
[K79A] 0.4 0.7 n.b.
[E81A] 2.3 2.3 0.5
[F85A] n.b. n.b. 0.8
[Q86A] 17.3 27.1 0.8
[K92A] 1.8 1.7 n.b.
[Q94A] 1.2 1.2 19.5
[Q94P] 3.8 2.9 5.3
[R97A] 34.2 13.4 n.b.
[I99A] 25.1 19.8 4.1
a) Contribution of the mutated residue to the overall binding energy is indicated
by bold, italic letters (contribution very strong) or only boldface letters
(contribution strong).
b) Both BMPR-IA variant proteins could only be produced in non-homogenous
form indicating variants that have lost the native BMPR-IA fold, thus these
variants were excluded from analysis.
c) n.b.: no binding. SPR data could not be fitted due to too low binding signal,
however, from the analyte concentration used in the analysis, a lower limit for
the binding affinity can be estimated to KD $5 mM.
doi:10.1371/journal.pone.0013049.t003
Table 4. Kinetics of the interaction of BMPR-IA with Fabs and
BMP-2.
BMPR-IAEC WT
koff [610
23 s
21] kon [610
4 M
21s
21] KD (nM)
BMP-2 1.9 7.2 27
AbD1556 1.7 8.8 20
AbD1564 7.1 15 49
doi:10.1371/journal.pone.0013049.t004
Figure 4. Comparison of the bound and unbound forms of BMPR-IA. (A) Structural superposition (Stereoview) of BMPR-IAEC bound to
AbD1556 (green) and bound to BMP-2 (magenta, PDB entry 1REW). The comparison shows that the short a-helix 1 that is observed in the complex
BMP-2:BMPR-IA is absent when BMPR-IA is bound to AbD1556. The b4b5-loop adopts two different conformations in the two BMPR-IA structures. (B)
(Stereoview) Structural alignment of the NMR-ensemble of BMPR-IAEC (Ca-trace of 21 structures in cyan, PDB entry 2K3G) and BMPR-IAEC bound to
AbD1556. The b4b5-loop of BMPR-IA bound to AbD1556 has only partial similarity to the structures of the NMR ensemble. (C–E) Comparison of the
b4b5-loop of BMPR-IA bound to BMP-2 (C), bound to AbD1556 (D) and for a representative conformer of the free form (E). The side chains of residues
Phe85, Gln86, Lys88 and Asp89 that play an important role in binding to BMP-2 or AbD1556 show very different orientations in all three structure
(forms).
doi:10.1371/journal.pone.0013049.g004
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measurable affinity for AbD1556 or BMP-2. Three of those
mutants (Y23D, F60A and M78A) have likely lost the native fold of
BMPR-IA, because these variant proteins could only be obtained
in non-homogeneous form and with very low yield. The BMPR-IA
variant F85A, however, seems structurally intact and binds to
neither AbD1556 nor BMP-2.
The same set of BMPR-IA variants was also tested for binding
to another Fab, AbD1564, which due to its BMP-2 neutralizing
properties must have a BMPR-IA epitope (at least partially)
overlapping with that of BMP-2. Unfortunately, the lack of
structural data for AbD1564 does not allow for a direct
comparison of the structural epitopes. However, the comparison
of both functional epitopes of BMPR-IA for binding to either
AbD1556 or AbD1564 shows that residues of BMPR-IA
contribute vastly different to the binding of the two Fab proteins
(Fig. 5B, Table 3). Whereas the mutation of a contact residue in
BMPR-IA results in a highly similar change in binding affinity for
BMP-2 and AbD1556 (as evident from the correlation factor
KD(BMPR-IA:BMP-2)/KD(BMPR-IA:AbD1556) being located
on or close to the diagonal in Fig. 5A), no correlation exists when
the contribution of individual BMPR-IA residues to binding
energy is compared for the interaction of BMPR-IA with
AbD1556 and AbD1564 (Fig. 5B). The results are surprising
since the functional epitopes of BMPR-IA for binding to BMP-2
and AbD1556 seem identical despite the fact that the structures of
BMPR-IA bound to either BMP-2 or AbD1556 differ significant-
ly. Specifically, the exchange of the BMPR-IA residues Phe85 and
Gln86 to alanine renders the binding to AbD1556 similar as to
BMP-2, although neither side chain directly contact the Fab
surface. A closer inspection of the kinetic rate constants of the
AbD1556-BMPR-IA mutant interaction shows that in the case of
BMPR-IA Q86A only the association rate is affected (Table 5,
Fig. 6). Since the interaction of Fab AbD1564 with BMPR-IA is
not affected by the mutation Q86A (Fig. 6C) a global misfolding
altering the binding properties of the BMPR-IA variant can be
ruled out. Analysis of the association and dissociation rates
strongly indicates that the binding mechanism of BMPR-IA to
AbD1556 and BMP-2 follows a selection-fit (or selection of
conformation) mechanism (Fig. 6). Thus the strong influence of
the mutations F85A and Q86A in BMPR-IA on binding to
AbD1556 is likely due to a shift in the conformer population
eliminating or reducing the fraction of molecules adopting the
conformation required for binding to AbD1556. Supportive of
Figure 5. Functional epitopes of AbD1156, AbD1564 and BMP-2. Mutational analysis of the BMPR-IA binding epitope and in vitro interaction
analysis shows that the contribution of residues within the epitope to the binding energy correlate for binding to AbD1556 and BMP-2 (A), whereas
the two Fab AbD1556 and AbD1564 clearly bind to BMPR-IA via a different mechanism (B).
doi:10.1371/journal.pone.0013049.g005
Table 5. Relative kinetic rate constants of the interaction of
BMPR-IA and variants thereof with BMP-2, AbD1556 and
AbD1564
a).
BMP-2 AbD1556 AbD1564
rel. koff rel. kon rel. koff rel. kon rel. koff rel. kon
BMPR-IA 1.0 1.0 1.0 1.0 1.0 1.0
[P34R] 1.0 0.6 0.8 0.8 0.7 0.7
[I62A] 24.0 1.5 17.5 0.7 1.1 0.6
[E64A] 0.9 0.8 2.7 1.3 0.7 1.4
[D67A] 0.8 0.8 1.8 1.1 -
b) -
b)
[K79A] 0.4 1.0 0.6 0.9 -
b) -
b)
[E81A] 2.5 1.4 2.7 1.3 0.7 1.4
[F85A] -
b) -
b) -
b) -
b) 1.1 1.4
[Q86A] 2.3 0.1 2.4 0.1 0.7 0.9
[K92A] 1.8 1.0 1.8 1.1 -
b) -
b)
[Q94A] 1.2 1.0 1.2 1.1 -
b) -
b)
[Q94P] 5.8 1.7 4.8 1.7 15.7 3.1
[R97A] -
b) -
b) 26.3 2.5 -
b) -
b)
[I99A] 6.0 0.2 6.4 0.4 1.3 0.3
a) Only BMPR-IA variants for which the native BMPR-IA fold can be assumed
were included in the analysis. Relative rate constants are shown, absolute rate
constants are given in Table 4a. Whether the mutation of the respective amino
acid residue to alanine affects the dissociation is marked by boldface letters, if
the association kinetics is affected rate constants are shown in italic letters.
Changes larger than 3fold are considered significant.
b) Due to the very fast interaction kinetics observed for those BMPR-IA variant
proteins, analysis of the rate constants was impossible, binding equilibrium
constants were thus obtained from analysis of the dose-dependency of
equilibrium binding.
doi:10.1371/journal.pone.0013049.t005
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e . g .7t o9 610
4 M
21s
21 for the BMPR-IA interaction with
AbD1556 or BMP-2, whereas the association with the second Fab
AbD1564 occurs twice as fast (1.5610
5 M
21s
21)( Table 4)[ 2 5 ] .
Furthermore, the observed effect that mutations at the periphery
of the interface influence the binding affinity, even though the
mutated residues are not directly contacting the binding partner,
is in concordance with the theory that those residues affect the
population equilibrium of the different conformers and thereby
indirectly affect binding [25]. In summary, the comparative
structure-/function analysis of the BMPR-IA interaction with the
Fab AbD1556 and its ligand BMP-2 suggests that the location of
the binding determinant, rather than its chemical nature, is the
most important factor contributing to the overall binding
energy.
Discussion
In this study, we present the structure of the BMP type I
receptor BMPR-IA bound to the antibody fragment AbD1556,
which is an efficient inhibitor for BMP mediated signalling. To
date, more than 1300 structures for antibodies, fragments thereof
(Fv, Fab, sFv, camelid antibodies) or complexes with antigens or
small molecule haptens are available in the RCSB structure
databank, demonstrating the enormous interest in this protein
class. Their versatile binding properties have been structurally and
functionally studied since the early 909s providing a wealth of data
on how antibodies in principle recognize and bind their target
molecules [26,27]. The Fab AbD1556 binding to the BMP
receptor IA is not an exception to the rules that have been derived
from other antibody structures. Thus the binding epitope of Fab
AbD1556 has the expected size for binding to a rather large
protein antigen, the binding site is dominated by the variable
region of the heavy chain, particularly by CDR3H (residues Glu99
to Phe107, Kabat numbering 95 to 100C), which lies in the centre
of the contact. The loop conformations of the CDRs L1, L2, H1
and H2 follow the classification of Chothia, exhibiting the
canonical structure classes 4, 1, 1 and 3, respectively [28,29].
The CDR3 loop of the light chain is unusually long and seems not
to obey any of the known classes. As observed in other antibody-
antigen structures, the number of serine residues is indeed
increased in the CDR loops. Due to the rather large size of the
antigen BMPR-IA, the binding epitope of the Fab is quite flat
maximizing the contact between the CDR loops and the antigen.
It therefore seems like that the antigen binding mechanism of the
Fab AbD1556 does not differ very much from those observed in
other antibody-antigen interactions.
Thus the far more interesting aspect lies in the structure of the
antigen, the BMP receptor type IA. The structure, when bound to
the neutralizing Fab AbD1556, reveals an epitope on BMPR-IA
highly overlapping structurally with that of BMPR-IA when
bound to its natural ligand BMP-2. Comparing the binding sites
on BMP-2 and AbD1556, which might be considered as an anti-
idiotypic BMP-2 potentially exhibiting a similar binding surface as
BMP-2, shows that there is very limited similarity in surface shape
(Fig. S5). In the BMPR-IA:BMP-2 complex, BMPR-IA is buried
in a deep, quite concave cleft on BMP-2, whereas in the
Fab:BMPR-IA complex the binding site on the Fab is very flat.
On the other hand, in both sites the epitope center is dominated
almost exclusively by hydrophobic amino acids, which are
surrounded by a ring of polar and/or charged residues, suggesting
that the surface chemistry involved are similar despite the
structural differences.
A previous NMR structure analysis of BMPR-IA illustrated that
the ligand-binding epitope of BMPR-IA is largely unordered in its
unbound form and subject to a large conformational rearrange-
ment upon BMP-2 binding [15]. The main changes are located in
the long loop between the b-strands 4 and 5 of the BMPR-IA
ectodomain. In its BMP-2 bound form this loop adopts a rigid
extended conformation with a short 1.5turn helix comprised of
residues Ser83 to Lys88 [11,12]. NMR titration studies using the
helix-inducing agent trifluoroethanol point towards an induced fit
mechanism, which seems to lead to a spontaneous helix induction
upon changes in the environment [15]. However, in the structure
of BMPR-IA bound to the Fab AbD1556 the b4b5-loop adopts a
rather different conformation, which resembles a mixture of the
conformation(s) found in the NMR structure ensemble and the
BMP-2 bound form. Thus the helix formation does not precede
complex formation and whether a helix is formed in the BMPR-IA
b4b5-loop depends on the nature of the binding partner. This
structural plasticity of the BMP type I receptor epitope, which
allows BMPR-IA to adapt to different binding partners without
deteriorating binding affinities to either one of the partners is
possibly a key mechanism by which proteins can achieve binding
to more than one interaction partner utilizing the same binding
site. The so-called binding promiscuity has become an increasingly
observed phenomenon in numerous protein superfamilies rather
than an exotic exception (for a limited number of examples, see
[7,30,31,32,33,34]). For some protein families, e.g. antibodies, T-
cell receptors and other ‘‘receptors’’ of the immune system,
Figure 6. SPR analysis of BMPR-IA binding to BMP-2 and Fab proteins. Sensorgram of the interaction of wildtype BMPR-IA (red) and the
BMPR-IA variant Q86A (blue) with BMP-2 (A), AbD1556 (B) and AbD1564 (C). The sensorgrams were recorded using BMPR-IA or the variant BMPR-IA
[Q86A] as analytes at a concentration of 250 nM. At time point 0 the analytes were added (association phase), at time point 300 s only buffer was
perfused allowing to monitor the dissociation of the receptor protein from the biosensor.
doi:10.1371/journal.pone.0013049.g006
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proteins is a generally accepted phenomenon, but it has still been
assumed that a particular antibody would still recognize only a
single antigen. An antibody binding to different antigens, i.e.
showing cross-reactivity, was considered rare and its promiscuous
binding due to structural similarities between the cognate antigens.
A promiscuous protein is defined as protein with a defined
sequence that can bind various partners (but still exhibits high
specificity for this particular group of partners) without utilizing
different epitopes, making promiscuity an incomprehensible
mystery in protein-protein recognition. In its most extreme form,
so-called hub proteins at central positions of interaction networks
were postulated, which supposedly bind to tens or even hundreds
of partners [35,36]. Although this finding possibly might explain
the numerical discrepancy between the rather small number of
genes and the complexity of the signaling network in complex
organisms such as humans [37], it raises questions about how a
single hub protein can interact with so many different partners
[38]. Several solutions to this logical obstacle have been proposed.
Many hub proteins exhibit a modular architecture in which
several different protein interaction domains, that typically bind
linear epitopes, are shuffled together [39]. Depending on post-
translational modifications or splicing, these hub proteins can form
different interaction complexes thereby enhancing the complexity.
The discovery of intrinsically disordered proteins has added
another powerful example how protein-protein interactions
(networks) can be extended [40]. The often under-appreciated
fact that proteins are inherently flexible, from side chain to
backbone level, allows proteins to adapt to different binding sites
[41,42]. Although neither BMPR-IA nor its BMP ligands are
classical hub proteins, the manifold interactions of BMPR-IA and
other BMP type I receptors with various BMPs as well as the
interaction of these BMPs with other receptors, co-receptors or
modulator proteins show similarities to hub proteins in these
interaction networks. Neither the ligand nor the receptor are
modular proteins, but modularity of binding epitopes has been
described to allow for promiscuity [43]. Cooperativity from using
two (or several) discontinuous binding elements as observed in the
interaction of the von Willebrand domain VWC1 of Crossveinless
2 with BMP-2 allows to combine the weak affinities of two small
epitopes and broader binding specificity [44]. Here the local
intrinsic disorder in the binding epitope of BMPR-IA allows
adaptation of its interface to very different binding partners. Even
though the Fab is not a physiological BMP interaction partner, the
very same mechanism, by selecting the matching conformation
from a pre-existing population, might also explain the promiscu-
ous binding of BMPR-IA to other BMPs, like BMP-6, -7 or GDF-5
[45] or to structurally unrelated molecules like Rgma/Dragon
[46]. As flexible loop elements in BMP type I receptors have
indeed been shown to modulate promiscuity and specificity
[13,47], further structural studies of protein-protein complexes
involving BMPR-IA are necessary to reveal whether and how
other binding partners utilize the conformational flexibility of
BMPR-IA for recognition and binding to its full extent.
Supporting Information
Figure S1 (A) B-factor distribution of the heavy chain Ca-
atoms of the four AbD1556 molecules in the asymmetric unit of
the AbD1556:BMPR-IA crystal. Elevated B-factors ($ 120A ˚ 2)
are observed for Ca-atoms in the loops of the CH-domain, which
are not stabilized by crystal-lattice contacts (see Fig S2). (B) As in
(A) but for the light chain of the four AbD1556 molecules in the
asymmetric unit. (C) As in (A) and (B) but for the Ca-atoms of
the BMPR-IA ectodomain of the four complexes AbD1556:
BMPR-IA.
Found at: doi:10.1371/journal.pone.0013049.s001 (0.63 MB TIF)
Figure S2 Analysis of the crystal lattice contacts of the CH
domain of AbD1556 (AbD1556H 1) (A) and BMPR-IA (BMPR-
IA4) (B) showing that the elevated B-factors (Fig. S1) observed in
these regions correlate with lack of contacts between residues of
these areas with symmetry-related molecules. The four complexes
AbD1556:BMPR-IA are shown as ribbon plot and color-coded by
the B-factor of the backbone (blue indicates B-factors of # 60A ˚ 2,
red indicates B-factors $ 120A ˚ 2), symmetry-related molecules
forming the crystal lattice are shown as Ca-trace colored in grey.
Found at: doi:10.1371/journal.pone.0013049.s002 (1.73 MB TIF)
Figure S3 Biological activity of the two BMPR-IA binding Fab
antibodies AbD1556 and AbD1564. (A) BMP-2 induces the
expression of alkaline phosphatase (ALP) in C2C12 cells in a dose-
dependent manner. The concentration for half-maximal response
(EC50) is about 19 6 1nM. (B) Both Fab AbD1556 and AbD1564
bind to a BMPR-IA epitope that overlaps with BMPR-IA binding
to BMP-2 and thus can neutralize BMP-2 activity in the above
ALP assay. BMP-2 was added at 20nM and increasing
concentrations of AbD1556 or AbD1564 were added. The
concentration for half-maximal inhibition is about 90nM for
AbD1556 and 60nM for AbD1564.
Found at: doi:10.1371/journal.pone.0013049.s003 (0.19 MB TIF)
Figure S4 (A) Ligplot analysis of the interaction of the Fab’s
AbD1556 VH domain and BMPR-IA. Hydrogen bonds are
indicated as green stippled lines, with distances between the
acceptor and donor atom shown. The buried surface area upon
complex formation is given in A ˚ 2 next to the residue name.
Residues of the Fab are shown with orange lines and annotated
with VH, residues of BMPR-IA are shown with blue lines and
labelled with R. (B) As in (A) but for the interaction of the Fab VL
domain and BMPR-IA.
Found at: doi:10.1371/journal.pone.0013049.s004 (1.09 MB TIF)
Figure S5 (A) Surface representation of the BMPR-IA binding
epitope of AbD1556. The surface is color-coded by amino acid
polarity with hydrophobic amino acids (A, C, F, G, H, I, L, M, P,
V, W, Y) in dark grey, with acidic residues in red (D, E), basic
amino acids marked in blue (K, R) and polar, uncharged residues
shown in green. Residues not participating in the binding epitope
are shown in lighter colors. (B) As in (A) but for the BMPR-IA
binding epitope of BMP-2 (PDB entry 1REW). BMP-2 oriented
such that BMPR-IA in the complexes AbD1556:BMPR-IA and
BMP-2:BMPR-IA (1REW) are structurally aligned. (C) As in (A)
but rotated by about 70u around the x-axis. (D) As in (B) but
rotated around the y-axis for about 70u. The top view of the
BMPR-IA binding epitopes of AbD1556 (A) and BMP-2 (B) show
a seemingly similar distribution of the amino acid chemistry at the
binding surface, e.g. a large central hydrophobic patch, surround-
ing polar or charged residues which (in part) occupy similar
positions (e.g. AbD1556 Asp50:BMP-2 Asp53; AbD1556
Trp101:BMP-2 Leu66/Ile62; AbD1556 Arg104:BMP-2 Lys101,
etc.). The side view (C,D), however, shows that surface
complementarity is rather limited with the curvature of
AbD1556 being flat and the BMP-2 surface being highly concave.
Found at: doi:10.1371/journal.pone.0013049.s005 (1.87 MB TIF)
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